农村居住与2型糖尿病治疗强化中磺脲类药物使用延迟趋势相关
该回顾性队列研究利用加拿大阿尔伯塔省2008年4月至2019年3月成人新使用二甲双胍者的行政健康记录,分析居住地(都市、城市、农村)与磺脲类药物配发记录的关系。171,759名新使用者中66,084人(38%)在平均1.5年后治疗强化,最常用为磺脲类(30,297人,46%)。调整混杂后,农村居住者使用磺脲类的可能性显著高于都市居民(调整OR 1.34,95%CI 1.29-1.39),且农村居民远离磺脲类使用的趋势延迟约4年。
要点
- 治疗强化时最常用药物为磺脲类,占30,297人(46%)。
- 观察初期农村磺脲类配发比例57%,高于城市54%和都市52%(P=0.009)。
- 农村居民磺脲类使用比例45%,高于城市35%和都市37%(P<0.001)。
核心结论
- 磺脲类药物配发沿城乡连续体存在差异,为继续研究不同地点的照护过程差异提供了基础。
研究设计与样本
- 回顾性队列研究,使用加拿大阿尔伯塔省2008年4月至2019年3月成人新使用二甲双胍者的行政健康记录。
- 采用多变量逻辑回归分析磺脲类治疗强化与居住地的关联。
主要发现
- 171,759名新使用二甲双胍者中66,084人(38%)在平均1.5年后治疗强化。
- 治疗强化时平均年龄55岁,62%为男性,27%为农村居民。
- 最常见的治疗强化降糖药为磺脲类,给予30,297人(46%)。
- 观察初期首次治疗强化时磺脲类配发比例农村57% vs 城市54% vs 都市52%(P=0.009)。
- 尽管全省比例随时间下降,农村居民磺脲类使用比例仍最高(45%)vs 城市(35%)vs 都市(37%)(P<0.001),农村居民远离磺脲类使用的趋势延迟约4年。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the intersection between location of residence along the rural-urban continuum (metropolitan, urban, and rural) and sulfonylurea dispensation records for the management of type 2 diabetes. RESEARCH DESIGN AND METHODS: This retrospective cohort study used administrative health records of adult new metformin users between April 2008 and March 2019 in Alberta, Canada. Multivariable logistic regression was performed to examine the association between sulfonylurea-based treatment intensification and location of residence. RESULTS: Treatment was intensified in 66,084 (38%) of 171,759 new metformin users after a mean of 1.5 years. At treatment intensification, mean age was 55 years, 62% of users were male, and 27% were rural residents. The most common antihyperglycemic drug, given to 30,297 people (46%) for treatment intensification, was a sulfonylurea. At the beginning of our observation period, the proportion of people dispensed a sulfonylurea at first treatment intensification was highest in rural (57%), compared with urban (54%) and metropolitan (52%) areas (P = 0.009). Although proportions decreased over time across the province, rural residents continued to constitute the highest proportion of sulfonylurea users (45%), compared with urban (35%) and metropolitan (37%) residents (P < 0.001), and the trend away from sulfonylurea use was delayed by ∼4 years for rural residents. Adjusting for potential sources of confounding, rural residence was associated with a significantly higher likelihood of using a sulfonylurea compared with metropolitan residence (adjusted odds ratio 1.34; 95% CI 1.29-1.39). CONCLUSIONS: Variation in sulfonylurea dispensation across the rural-urban continuum provides a basis for continued research in the differences in process of care by location.
引用
- Nagy DK, Bresee LC, Eurich DT, et al. Rural Residence Is Associated With a Delayed Trend Away From Sulfonylurea Use for Treatment Intensification of Type 2 Diabetes. Diabetes Care. 2023. PMID: 36637880. doi:10.2337/dc22-1223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。